ExodusPoint Capital Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.2M Buy
148,133
+68,046
+85% +$10.5M 0.19% 74
2025
Q4
$13.9M Buy
+80,087
New +$14.6M 0.11% 170
2025
Q3
Sell
-92,717
Closed -$9.33M 1764
2025
Q2
$9.33M Buy
92,717
+4,934
+6% +$377K 0.08% 246
2025
Q1
$6.7M Buy
+87,783
New +$6.71M 0.07% 321
2024
Q4
Sell
-85,183
Closed -$6.22M 1755
2024
Q3
$6.22M Buy
85,183
+42,578
+100% +$3.14M 0.04% 347
2024
Q2
$2.85M Buy
+42,605
New +$1.65M 0.02% 652
2023
Q4
Sell
-33,165
Closed -$837K 1743
2023
Q3
$837K Buy
+33,165
New +$758K 0.01% 1022
2023
Q1
Sell
-75,227
Closed -$1.5M 1933
2022
Q4
$1.5M Sell
75,227
-153,307
-67% -$2.96M 0.02% 765
2022
Q3
$4.92M Buy
228,534
+213,093
+1,380% +$5.11M 0.06% 409
2022
Q2
$304K Buy
+15,441
New +$324K ﹤0.01% 1530
2021
Q2
Sell
-67,008
Closed -$2.28M 2568
2021
Q1
$2.28M Buy
67,008
+3,690
+6% +$141K 0.03% 522
2020
Q4
$2.11M Buy
63,318
+55,132
+673% +$2.01M 0.02% 527
2020
Q3
$263K Sell
8,186
-5,730
-41% -$165K 0.01% 1344
2020
Q2
$383K Buy
+13,916
New +$330K 0.01% 1198
2020
Q1
Sell
-24,072
Closed -$575K 1347
2019
Q4
$575K Buy
24,072
+2,106
+10% +$42.8K 0.01% 790
2019
Q3
$387K Buy
+21,966
New +$424K 0.01% 771

Other funds holding INSM

ExodusPoint Capital Management's INSM Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Insmed (INSM) stake by 85% in Q1 2026, buying an estimated $10.5M and bringing the position to 148,133 shares worth $24.2M. The position accounts for 0.19% of the portfolio, ranked #74.

ExodusPoint Capital Management first reported a position in INSM in Q3 2019 and has held it in 16 quarters since. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • ExodusPoint Capital Management held 148,133 shares of Insmed worth $24.2M as of Q1 2026.
  • ExodusPoint Capital Management bought 68,046 Insmed shares in Q1 2026, an estimated $10.5M.
  • Insmed made up 0.19% of ExodusPoint Capital Management's portfolio in Q1 2026, its #74 holding.
  • ExodusPoint Capital Management first reported a position in Insmed in Q3 2019 and has held it in 16 quarters since.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.